• Transcept Pharmaceuticals Inc., of Point Richmond, Calif., reported a net loss of approximately $12 million for the 12 months ending Dec. 31, including a fourth-quarter net loss of approximately $6.6 million, compared to a net loss of approximately $3.9 million and net income of approximately $5.3 million, respectively, in the same periods the previous year.